106 related articles for article (PubMed ID: 23483626)
1. Impact of hepatitis C virus infection on clinical outcome in recipients after allogeneic hematopoietic cell transplantation.
Nakasone H; Kurosawa S; Yakushijin K; Taniguchi S; Murata M; Ikegame K; Kobayashi T; Eto T; Miyamura K; Sakamaki H; Morishima Y; Nagamura T; Suzuki R; Fukuda T
Am J Hematol; 2013 Jun; 88(6):477-84. PubMed ID: 23483626
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents.
Kyvernitakis A; Mahale P; Popat UR; Jiang Y; Hosry J; Champlin RE; Torres HA
Biol Blood Marrow Transplant; 2016 Apr; 22(4):717-722. PubMed ID: 26712592
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
[TBL] [Abstract][Full Text] [Related]
4. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation.
Parody R; Martino R; Rovira M; Vazquez L; Vázquez MJ; de la Cámara R; Blazquez C; Fernández-Avilés F; Carreras E; Salavert M; Jarque I; Martín C; Martínez F; López J; Torres A; Sierra J; Sanz GF;
Biol Blood Marrow Transplant; 2006 Jul; 12(7):734-48. PubMed ID: 16785063
[TBL] [Abstract][Full Text] [Related]
5. Renal transplantation offers a better survival in HCV-infected ESRD patients.
Sezer S; Ozdemir FN; Akcay A; Arat Z; Boyacioglu S; Haberal M
Clin Transplant; 2004 Oct; 18(5):619-23. PubMed ID: 15344970
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers.
Marroquin CE; Marino G; Kuo PC; Plotkin JS; Rustgi VK; Lu AD; Edwards E; Taranto S; Johnson LB
Liver Transpl; 2001 Sep; 7(9):762-8. PubMed ID: 11552208
[TBL] [Abstract][Full Text] [Related]
7. Effect of chronic viral hepatitis on graft survival in Saudi renal transplant patients.
Mitwalli AH; Alam A; Al-Wakeel J; Al Suwaida K; Tarif N; Schaar TA; Al Adbha B; Hammad D
Nephron Clin Pract; 2006; 102(2):c72-80. PubMed ID: 16244496
[TBL] [Abstract][Full Text] [Related]
8. Impact of HCV infection on first cadaveric renal transplantation, a single center experience.
Lin HH; Huang CC; Huang JY; Yang CW; Wu MS; Fang JT; Yu CC; Chiang YJ; Chu SH
Clin Transplant; 2004 Jun; 18(3):261-6. PubMed ID: 15142046
[TBL] [Abstract][Full Text] [Related]
9. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
[TBL] [Abstract][Full Text] [Related]
10. Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data.
Waki K; Sugawara Y; Tamura S; Mieno MN; Yamashiki N; Kadowaki T; Kokudo N
Transplantation; 2011 Oct; 92(7):809-14. PubMed ID: 21832961
[TBL] [Abstract][Full Text] [Related]
11. Impact of anti-hepatitis C virus (HCV) antibody on outcomes in renal transplant recipients infected with HCV.
Minz M; Sharma A; Das A; Chawla Y
Transplant Proc; 2008 Sep; 40(7):2386-8. PubMed ID: 18790242
[TBL] [Abstract][Full Text] [Related]
12. Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial.
Markova M; Barker JN; Miller JS; Arora M; Wagner JE; Burns LJ; MacMillan ML; Douek D; DeFor T; Tan Y; Repka T; Blazar BR; Weisdorf DJ
Bone Marrow Transplant; 2007 Feb; 39(4):193-9. PubMed ID: 17220905
[TBL] [Abstract][Full Text] [Related]
13. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
Khapra AP; Agarwal K; Fiel MI; Kontorinis N; Hossain S; Emre S; Schiano TD
Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation.
Locasciulli A; Bruno B; Alessandrino EP; Meloni G; Arcese W; Bandini G; Cassibba V; Rotoli B; Morra E; Majolino I; Alberti A; Bacigalupo A;
Bone Marrow Transplant; 2003 Feb; 31(4):295-300. PubMed ID: 12621466
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic hematopoietic cell transplantation for chronic myelofibrosis in Australia and New Zealand: older recipients receiving myeloablative conditioning at increased mortality risk.
Nivison-Smith I; Dodds AJ; Butler J; Bradstock KF; Ma DD; Simpson JM; Szer J
Biol Blood Marrow Transplant; 2012 Feb; 18(2):302-8. PubMed ID: 21620988
[TBL] [Abstract][Full Text] [Related]
16. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Duarte RF; Canals C; Onida F; Gabriel IH; Arranz R; Arcese W; Ferrant A; Kobbe G; Narni F; Deliliers GL; Olavarría E; Schmitz N; Sureda A
J Clin Oncol; 2010 Oct; 28(29):4492-9. PubMed ID: 20697072
[TBL] [Abstract][Full Text] [Related]
18. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
[TBL] [Abstract][Full Text] [Related]
19. [The effect of hepatitis B virus infection on the outcome of hematopoietic stem cell transplantation].
Du H; Wang M; Yang DL; Huang Y; Han MZ
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Apr; 29(4):387-91. PubMed ID: 18844000
[TBL] [Abstract][Full Text] [Related]
20. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus.
Taner CB; Bulatao IG; Keaveny AP; Willingham DL; Pungpapong S; Perry DK; Rosser BG; Harnois DM; Aranda-Michel J; Nguyen JH
Liver Transpl; 2011 Jun; 17(6):641-9. PubMed ID: 21618684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]